Skip to main content
. 2020 Oct 23;26(2):399–408. doi: 10.1007/s10147-020-01811-w

Table 2.

Reasons of protocol discontinuation and post-protocol treatment details

Reason of protocol discontinuation n = 46 Post-treatment details n = 46 %
Surgery 8 R0 resection 5 10.9
R2 resection 3 6.5
Patient's withdrawal 1 FOLFIRI + Bmab 1 2.2
Disease progression 1 FOLFOXIRI + Bmab 1 2.2
Adverse event 9 FOLFOXIRI ± Bmab 4 8.7
FOLFIRI + Bmab 2 4.3
FL + Bmab 1 2.2
Capecitabine + Bmab 1 2.2
BSC 1 2.2
Protocol completion* 27 FOLFOXIRI + Bmab 18 39.1
FOLFIRI ± Bmab 8 17.4
FL + Bmab 1 2.2

*Treatment performed in the 12th cycle of protocol therapy

R0 resection curative resection, Bmab bevacizumab, FL infusional 5-fluorouracil and leucovorin, BSC best supportive care